Spain Retail Sales Expand Most In 20 Months

By RTTNews Staff Writer   ✉   | Published:

Spain's retail sales rose for the second straight month in January, and at the fastest pace in twenty months, underpinned by a sharp increase in non-food product turnover, data from the statistical office INE showed on Friday.

Retail sales posted an annual growth of 5.5 percent in January, after a 4.8 percent rebound in the previous month.

Further, this was the strongest rate of growth since May 2021, when sales had surged 19.5 percent.

Non-food product sales alone surged 15.0 percent yearly in January, while those of food products dropped 1.7 percent.

On an unadjusted basis, the retail sales growth accelerated notably to 7.1 percent from 3.7 percent.

Month-on-month, retail sales increased 0.4 percent in January versus a 0.5 percent gain in December. Sales advanced for the sixth successive month.

Both food and non-food product sales rose from a month ago. Food sales were up 0.5 percent and non-food products posted a bigger increase of 5.4 percent.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Automaker General Motors Co. announced a voluntary separation program for its employees in an effort to accelerate the normal attrition process and the resulting cost savings. The move is part of its efforts to cut $2 billion in structural costs over the next two years. In a regulatory filing, the company said it expects to take a pretax charge of up to $1.5 billion related to the buyouts. Walnut, California-based Bedshe International Co. Ltd. is recalling about 350,000 units of Bedsure Electric heating blankets and pads citing fire and thermal burn hazards, the U.S. Consumer Product Safety Commission said. The recall involves Bedsure electric heating blankets with model numbers BS-HB5060, BS-HB6284, BS-HB7284, and BS-LV0A. Further, Bedsure electric heating pads. Sandoz, the generics and biosimilars division of Swiss drug major Novartis AG, is recalling about 156,750 units of Aprepitant capsules and Lidocaine and Prilocaine cream prescription drugs, the U.S. Consumer Product Safety Commission said. The recall was due to risk of poisoning to childern for failure to meet child resistant packaging requirement.